北京招聘

FibroGen is a leading US biotechnology company and the world leader in developing several major breakthrough technologies in medicine including Hypoxia-Inducible Factor (HIF)，Prolyl Hydroxylase Inhibition (PHI) and Connective Tissue Growth Factor (CTGF). FibroGen established a WOFE entity in China FibroGen China, and plans to transfer its technologies from the US in a manner that will make FibroGen China the 1st ever world-class，research-based biopharmceutical company in China.
FibroGen是美国一家一流的生物科技公司，是开发医学领域多项重大突破性技术的世界巨头，包括低氧诱导因子（HIF）、脯氨酰羟化酶抑制（PHI）和结缔组织生长因子（CTGF）。Fibrogen 在2011年建立了FibroGen China (中国珐博进)独资企业，并计划将它的技术从美国转让给我们中国公司。 珐博进将成为中国前所未有、世界一流、专注于研究的生物制药企业